CLODEW Trademark

Trademark Overview


On Friday, September 6, 2013, a trademark application was filed for CLODEW with the United States Patent and Trademark Office. The USPTO has given the CLODEW trademark a serial number of 86057907. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by DAEWOONG PHARMACEUTICAL CO., LTD.. The CLODEW trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; Antibiotic preparations; Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Dermatological pharmaceutical products; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations, namely, a...
clodew

General Information


Serial Number86057907
Word MarkCLODEW
Filing DateFriday, September 6, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number4623497
Registration DateTuesday, October 21, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Page 1, lines 2-3, should be deleted, and "223-23, Sangdaewon-Dong, Joongwon-Ku," should be reinserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAdjuvants for medical purposes; Antibiotic preparations; Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Dermatological pharmaceutical products; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for central nerve treatment; Pharmaceutical preparations for diagnosis, namely, protein arrays for medical diagnosis purposes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for respiratory organs; Pharmaceutical preparations for chemical disorder treatment; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction
Pseudo MarkCLO DEW
Translation of Words in MarkThe wording "CLODEW" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDAEWOONG PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSungnam-city Kyunggido
KR

Party NameDAEWOONG PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSungnam-city Kyunggido
KR

Party NameDAEWOONG PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSungnam-city Kyunggido
KR

Trademark Events


Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (6-YR)
Monday, October 21, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 23, 2015CORRECTION UNDER SECTION 7 ¿ PROCESSED
Tuesday, January 20, 2015TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, December 10, 2014POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, December 10, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 1, 2014TEAS SECTION 7 REQUEST RECEIVED
Tuesday, October 21, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, August 12, 2014WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 3, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 10, 2014ASSIGNED TO LIE
Wednesday, May 28, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 17, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2013NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2013NON-FINAL ACTION WRITTEN
Tuesday, December 17, 2013ASSIGNED TO EXAMINER
Monday, October 14, 2013TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, October 14, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 17, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, September 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 10, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 10, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 10, 2013NEW APPLICATION ENTERED IN TRAM